COMPLETE PLATELET RECOVERY AFTER TREATMENT OF<i>HELICOBACTER PYLORI</i>INFECTION IN A CHILD WITH CHRONIC IMMUNE THROMBOCYTOPENIC PURPURA: A Case Report

Kürekçi, Ahmet Emin; Atay, Avni; Sarıcı, Serdar Ümit; Özcan, Okan

doi:10.1080/08880010490500962

Cited by 18 publications

(6 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Worldwide, an association between ITP and H. pylori has been found in 11 single‐case reports: five in the European continent with three in Italy [69–71], one in Spain [72] and one in Turkey [73], and six in the Asian continent, all in Japan [74–79]. Also, until now, 23 series have been reported: in the European continent there are nine reported series [12–19,80] with a total of 414 patients with ITP, 258 (62.3%) were infected with H. pylori .…”

Section: Discussionmentioning

confidence: 99%

Proof of an Association between Helicobacter pylori and Idiopathic Thrombocytopenic Purpura in Latin America

Campuzano-Maya¹

2007

Helicobacter

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Proof of an Association between Helicobacter pylori and Idiopathic Thrombocytopenic Purpura in Latin America

Campuzano-Maya¹

2007

Helicobacter

View full text Add to dashboard Cite

show abstract

“…Besides the tests already suggested in the guidelines for acute ITP, the Helicobacter pylori evaluation is recommended to exclude the infective nature of thrombocytopenia (8.8 – A) [29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45]. The stool antigen test is preferable because it is simple, cheap and comparable to the urea breath test [46,47,48].…”

Section: Resultsmentioning

confidence: 99%

Management of Chronic Childhood Immune Thrombocytopenic Purpura: AIEOP Consensus Guidelines

et al. 2009

View full text Add to dashboard Cite

Background/Objective: The management of chronic childhood idiopathic thrombocytopenic purpura (ITP) is distinct from acute ITP. Similar to the publication on acute ITP guidelines, the AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) considered it appropriate to develop consensus guidelines for chronic childhood ITP to provide useful and shared information for physicians, healthcare professionals, parents and patients. Design/Methods: A preliminary, evidence-based document issued by a select group of AIEOP pediatric hematologists was discussed, modified and approved during a Consensus Conference according to procedures previously validated by the AIEOP Board. Results: The guidelines give prominence to the periodical reevaluation of all the etiological hypotheses of thrombocytopenia in relation to its clinical condition. The majority of chronic ITP children do not require treatment, especially if bleeding is absent or minimal. The treatment decision depends on several factors other than the platelet count, and treatment options are suggested in relation to the therapeutic scenarios. Recommendations are given regarding support for surgery, particular hemorrhagic conditions, daily activities/sports, as well as for vaccines and drugs. Experimental treatments are also discussed.

show abstract

“…The medical literature subsequently reported similar cases in Japan [142][143][144][145][146], Italy [147][148][149], and Turkey [150].…”

Section: H Pylori and Immune Thrombocytopeniamentioning

confidence: 99%

Helicobacter pylori and Hematologic Diseases

Campuzano-Maya¹

2016

Extradigestive Manifestations of Helicobacter Pylori Infection - An Overview

View full text Add to dashboard Cite

Helicobacter pylori infection is the most common infection of the human species, with developing countries displaying a marked disadvantage in contrast to developing countries. While H. pylori infection is asymptomatic in most infected individuals, it is intimately related to malignant diseases of the stomach, such as gastric cancer and gastric MALT lymphoma, as well as benign diseases, for example chronic gastritis and duodenal and gastric peptic ulcers. Since the discovery that gastric mucosa could be colonized by bacteria, evidence of greater than 50 extragastric manifestations has been reported, linking H. pylori infection and the development of diseases associated with cardiology, dermatology, endocrinology, obstetrics and gynecology, hematology, pneumology, neurology, odontology, ophthalmology, otorhinolaryngology, and pediatrics. This chapter presents the extragastric manifestations of H. pylori infection expressed through hematologic diseases; particularly those included in the international consensus, and discusses guidelines for the management of H. pylori infection, such as iron deficiency, vitamin B 12 (cobalamin) deficiency, and immune thrombocytopenia. Other manifestations reviewed include immune neutropenia, antiphospholipid syndrome, and plasma cell dyscrasias, such us monoclonal gammopathy of undetermined significance, multiple myeloma, and Henoch-Schönlein purpura.

show abstract

COMPLETE PLATELET RECOVERY AFTER TREATMENT OFHELICOBACTER PYLORIINFECTION IN A CHILD WITH CHRONIC IMMUNE THROMBOCYTOPENIC PURPURA: A Case Report

Cited by 18 publications

References 12 publications

Proof of an Association between Helicobacter pylori and Idiopathic Thrombocytopenic Purpura in Latin America

Proof of an Association between Helicobacter pylori and Idiopathic Thrombocytopenic Purpura in Latin America

Management of Chronic Childhood Immune Thrombocytopenic Purpura: AIEOP Consensus Guidelines

Helicobacter pylori and Hematologic Diseases

Contact Info

Product

Resources

About